Solution NMR characterization of WT CXCL8 monomer and dimer binding to CXCR1 N-terminal domain

Prem Raj B Joseph, Krishna Rajarathnam

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Chemokine CXCL8 and its receptor CXCR1 are key mediators in combating infection and have also been implicated in the pathophysiology of various diseases including chronic obstructive pulmonary disease (COPD) and cancer. CXCL8 exists as monomers and dimers but monomer alone binds CXCR1 with high affinity. CXCL8 function involves binding two distinct CXCR1 sites - the N-terminal domain (Site-I) and the extracellular/transmembrane domain (Site-II). Therefore, higher monomer affinity could be due to stronger binding at Site-I or Site-II or both. We have now characterized the binding of a human CXCR1 N-terminal domain peptide (hCXCR1Ndp) to WT CXCL8 under conditions where it exists as both monomers and dimers. We show that the WT monomer binds the CXCR1 N-domain with much higher affinity and that binding is coupled to dimer dissociation. We also characterized the binding of two CXCL8 monomer variants and a trapped dimer to two different hCXCR1Ndp constructs, and observe that the monomer binds with ∼10- to 100-fold higher affinity than the dimer. Our studies also show that the binding constants of monomer and dimer to the receptor peptides, and the dimer dissociation constant, can vary significantly as a function of pH and buffer, and so the ability to observe WT monomer peaks is critically dependent on NMR experimental conditions. We conclude that the monomer is the high affinity CXCR1 agonist, that Site-I interactions play a dominant role in determining monomer vs. dimer affinity, and that the dimer plays an indirect role in regulating monomer function.

Original languageEnglish (US)
Pages (from-to)81-92
Number of pages12
JournalProtein Science
Volume24
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Dimers
Interleukin-8A Receptors
Monomers
Nuclear magnetic resonance
Peptide Receptors
Interleukin-8
Chronic Obstructive Pulmonary Disease
Lung Neoplasms
Buffers
Binding Sites
Infection
Protein Domains
Pulmonary diseases
Peptides

Keywords

  • affinity
  • CXCL8
  • human CXCR1 N-domain
  • monomer-dimer equilibrium
  • solution NMR

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology

Cite this

Solution NMR characterization of WT CXCL8 monomer and dimer binding to CXCR1 N-terminal domain. / Joseph, Prem Raj B; Rajarathnam, Krishna.

In: Protein Science, Vol. 24, No. 1, 01.01.2015, p. 81-92.

Research output: Contribution to journalArticle

@article{1a068abd40fe48dcb3db49483ddee2bc,
title = "Solution NMR characterization of WT CXCL8 monomer and dimer binding to CXCR1 N-terminal domain",
abstract = "Chemokine CXCL8 and its receptor CXCR1 are key mediators in combating infection and have also been implicated in the pathophysiology of various diseases including chronic obstructive pulmonary disease (COPD) and cancer. CXCL8 exists as monomers and dimers but monomer alone binds CXCR1 with high affinity. CXCL8 function involves binding two distinct CXCR1 sites - the N-terminal domain (Site-I) and the extracellular/transmembrane domain (Site-II). Therefore, higher monomer affinity could be due to stronger binding at Site-I or Site-II or both. We have now characterized the binding of a human CXCR1 N-terminal domain peptide (hCXCR1Ndp) to WT CXCL8 under conditions where it exists as both monomers and dimers. We show that the WT monomer binds the CXCR1 N-domain with much higher affinity and that binding is coupled to dimer dissociation. We also characterized the binding of two CXCL8 monomer variants and a trapped dimer to two different hCXCR1Ndp constructs, and observe that the monomer binds with ∼10- to 100-fold higher affinity than the dimer. Our studies also show that the binding constants of monomer and dimer to the receptor peptides, and the dimer dissociation constant, can vary significantly as a function of pH and buffer, and so the ability to observe WT monomer peaks is critically dependent on NMR experimental conditions. We conclude that the monomer is the high affinity CXCR1 agonist, that Site-I interactions play a dominant role in determining monomer vs. dimer affinity, and that the dimer plays an indirect role in regulating monomer function.",
keywords = "affinity, CXCL8, human CXCR1 N-domain, monomer-dimer equilibrium, solution NMR",
author = "Joseph, {Prem Raj B} and Krishna Rajarathnam",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/pro.2590",
language = "English (US)",
volume = "24",
pages = "81--92",
journal = "Protein Science",
issn = "0961-8368",
publisher = "Cold Spring Harbor Laboratory Press",
number = "1",

}

TY - JOUR

T1 - Solution NMR characterization of WT CXCL8 monomer and dimer binding to CXCR1 N-terminal domain

AU - Joseph, Prem Raj B

AU - Rajarathnam, Krishna

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Chemokine CXCL8 and its receptor CXCR1 are key mediators in combating infection and have also been implicated in the pathophysiology of various diseases including chronic obstructive pulmonary disease (COPD) and cancer. CXCL8 exists as monomers and dimers but monomer alone binds CXCR1 with high affinity. CXCL8 function involves binding two distinct CXCR1 sites - the N-terminal domain (Site-I) and the extracellular/transmembrane domain (Site-II). Therefore, higher monomer affinity could be due to stronger binding at Site-I or Site-II or both. We have now characterized the binding of a human CXCR1 N-terminal domain peptide (hCXCR1Ndp) to WT CXCL8 under conditions where it exists as both monomers and dimers. We show that the WT monomer binds the CXCR1 N-domain with much higher affinity and that binding is coupled to dimer dissociation. We also characterized the binding of two CXCL8 monomer variants and a trapped dimer to two different hCXCR1Ndp constructs, and observe that the monomer binds with ∼10- to 100-fold higher affinity than the dimer. Our studies also show that the binding constants of monomer and dimer to the receptor peptides, and the dimer dissociation constant, can vary significantly as a function of pH and buffer, and so the ability to observe WT monomer peaks is critically dependent on NMR experimental conditions. We conclude that the monomer is the high affinity CXCR1 agonist, that Site-I interactions play a dominant role in determining monomer vs. dimer affinity, and that the dimer plays an indirect role in regulating monomer function.

AB - Chemokine CXCL8 and its receptor CXCR1 are key mediators in combating infection and have also been implicated in the pathophysiology of various diseases including chronic obstructive pulmonary disease (COPD) and cancer. CXCL8 exists as monomers and dimers but monomer alone binds CXCR1 with high affinity. CXCL8 function involves binding two distinct CXCR1 sites - the N-terminal domain (Site-I) and the extracellular/transmembrane domain (Site-II). Therefore, higher monomer affinity could be due to stronger binding at Site-I or Site-II or both. We have now characterized the binding of a human CXCR1 N-terminal domain peptide (hCXCR1Ndp) to WT CXCL8 under conditions where it exists as both monomers and dimers. We show that the WT monomer binds the CXCR1 N-domain with much higher affinity and that binding is coupled to dimer dissociation. We also characterized the binding of two CXCL8 monomer variants and a trapped dimer to two different hCXCR1Ndp constructs, and observe that the monomer binds with ∼10- to 100-fold higher affinity than the dimer. Our studies also show that the binding constants of monomer and dimer to the receptor peptides, and the dimer dissociation constant, can vary significantly as a function of pH and buffer, and so the ability to observe WT monomer peaks is critically dependent on NMR experimental conditions. We conclude that the monomer is the high affinity CXCR1 agonist, that Site-I interactions play a dominant role in determining monomer vs. dimer affinity, and that the dimer plays an indirect role in regulating monomer function.

KW - affinity

KW - CXCL8

KW - human CXCR1 N-domain

KW - monomer-dimer equilibrium

KW - solution NMR

UR - http://www.scopus.com/inward/record.url?scp=84928967172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928967172&partnerID=8YFLogxK

U2 - 10.1002/pro.2590

DO - 10.1002/pro.2590

M3 - Article

VL - 24

SP - 81

EP - 92

JO - Protein Science

JF - Protein Science

SN - 0961-8368

IS - 1

ER -